Treating late relapse of paediatric ALL

Share :
Published: 2 Dec 2021
Views: 184
Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany

Dr Arend von Stackelberg speaks to ecancer about a talk he gave at the recent ALL Assembly 2021 meeting on 'treating late relapse of paediatric ALL'.

He discusses what the current options are for treating patients depending on MRD status and goes into the genetic subgroups which tend to have poorer outcomes.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.